| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |